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Received September 4, 2012; accepted May 31, 2013AbstractBackground: Stroke is the leading cause of adult disability and mortality in Taiwan, resulting in a tremendous burden on the healthcare system.
The purpose of this study was to characterize disease burden by evaluating readmissions, mortality, and medical cost during the first year after
acute stroke under the National Health Insurance (NHI) program.
Methods: This retrospective cohort study extracted information about patients hospitalized with acute stroke from claims data of 200,000
randomly sampled NHI enrollees in Taiwan, with a 1-year follow-up duration. The incidence of the first-year adverse events (AEs) indicated by
readmissions or mortality, and the amount of the first-year medical cost (FYMC) were assessed with predictive factors explored. Additionally,
we also estimated the cost per life and life-year saved.
Results: There were 2368 first-ever stroke patients in our study, including those with subarachnoid hemorrhage (SAH) 3.3%, intracerebral
hemorrhage (ICH) 17.9%, ischemic stroke (IS) 49.8%, and transient ischemic attack/other ill-defined cerebrovascular diseases (TIA/unspecified)
29.0%; each stroke type was identified with an all-cause AE of 59.0%, 63.0%, 48.6%, and 46.8%, respectively. Readmissions were mainly
because of acute recurrent stroke or the late effects of previous stroke, respiratory disease/infections, heart/circulatory disease, and diseases of
the digestive system. Advanced age, hemorrhagic stroke type, respiratory distress/infections, and greater comorbidities were predictive of
increased AE risk. Admission to neurology/rehabilitation wards, undertaking neurosurgery, or use of inpatient/outpatient rehabilitation was less
likely to incur AEs. Initial hospitalization, readmission, and ambulatory care constituted 44%, 29%, and 27%, respectively, of FYMC with the
initial length of stay being the most reliable predictor. The FYMCs were NT $217,959, $246,358, $168,003, and $122,084 for SAH, ICH, IS, and
TIA/unspecified, respectively. The cost per life saved were estimated to be NT $435,919, $384,028, $196,281, and $138,888, whereas cost per
life-year saved were estimated to be NT$43,926, $48,019, $97,830, and $188,770 for SAH, ICH, IS, and TIA/unspecified, respectively.
Conclusion: Half of the patients encountered readmission or death during the first year after stroke. Patients with advanced age, more com-
plications, or comorbidities during initial stay tended to be highly vulnerable to AE occurrence, whereas TIA/unspecified stroke carried no less
risk for AEs. FYMC or estimated cost per life saved for IS or TIA/unspecified was lower relative to SAH or ICH; however, their estimated cost
per life-year saved became higher because of reduced life expectancy.
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Stroke results in a tremendous healthcare burden in Taiwan,
with costs associated with initial and recurrent hospitalization
being the major determinants.1,2 The need for patient read-
mission may reflect unsolved problems upon initial discharge,
inadequacy of discharge planning or post-hospital care,
occurrence of new health problems, or exacerbation of existing
disorders.311 In the past decade, there have been several
studies which investigated readmissions6,7,12 or mortality1316
after acute stroke in Taiwan, but few of these studies addressed
the medical cost,17,18 or the relationship between medical cost
and healthcare outcomes.19 Further investigation and explo-
ration of patient readmission, mortality, and medical cost after
stroke will more effectively spotlight the best strategies for
secondary prevention, and help to delineate the utilization
patterns likely to change over time and in response to
healthcare reform.39,12,20,21
National Health Insurance (NHI) in Taiwan is a single-
payer, universal program enrolling 99% of the population
with a comprehensive benefit scheme since 1995.22,23 Despite
the potential negative effect of cost containment measures on
stroke care outcome,14 the NHI program has weathered the
challenges of more than a decade, and its stable costs and short
wait times for healthcare have garnered worldwide atten-
tion.23,24 By using NHI claims data of stroke patients sampled
from a nationally representative cohort, this study aimed to
examine readmissions, mortality, and medical cost during the
first year after acute stroke, with their predictive factors
explored at the healthcare system level, thereby neutralizing
the ability to pay issue. In addition, cost per life and per life-
year saved for different stroke types were estimated and
compared.
2. Methods2.1. Data source and patients in the studyThe National Health Insurance Research database
(NHIRD), maintained by the National Health Research In-
stitutes (NHRI), is population-based and derived from the
claims data of the NHI program. In order to facilitate medical
research and inquiry, information from the NHIRD is provided
to scientists in Taiwan. This retrospective cohort study utilized
the Longitudinal Health Insurance Database 2000 (LHID
2000), a subset of NHIRD, as a representative cohort to
identify a stroke sample.25 LHID 2000 contains 200,000 in-
dividuals randomly sampled from the Registry for Benefi-
ciaries of the NHIRD out of approximately 23.72 million NHI
enrollees at year 2000. The distribution of age, sex, and health
service utilization of the cohort are known to resemble the
entire population in Taiwan. Virtually all patients suffering
from stroke are hospitalized under the NHI program, regard-
less of the severity.
Patients were selected from the NHI inpatient files with
principal discharge diagnosis being acute stroke (ICD-9-CM
codes 430 to 437) between January 1997 and December2002. All relevant files from the LHID 2000 (including inpa-
tient expenditures/details of orders by admissions, details of
emergency room (ER) prescription, ambulatory care expen-
ditures/details of orders by visits, prescriptions/expenditure
dispensed at contracted pharmacies, and registry for benefi-
ciaries/contracted medical facilities) were retrieved and
compiled into an analytical file at the patient-level, spanning
from 1996 through 2003. The first admission of each patient
during the study period was considered as the index stroke.
The admission date of the index stroke or any emergency room
stay preceding that event was regarded as the date of onset.
The length of stay (LOS) during the index stroke was defined
as covering direct transfers to any acute or sub-acute unit
along with the initial acute stay. Therefore, patients with a
complicated or rehabilitation transfer that was contiguous with
the initial stay had the extra hospitalization regarded as a
continuation of the index episode rather than a read-
mission.7,9,26 To approximate an incident cohort of first-ever
stroke, patients with medical records for acute or late effects
of stroke (438) prior to the index stroke were excluded. This
resulted in a first-ever stroke sample from 1997 to 2002, and
followed for a 12-month period up to December 31, 2003. The
detailed methodology has been described elsewhere.19,27,282.2. Patient characteristicsCharacteristics of the patients were collected, which
included demographics (age, sex, and onset year), clinical
characteristics (stroke type, stroke severity proxies, brain im-
aging, comorbidity, use of inpatient or outpatient rehabilita-
tion, initial LOS, and outpatient department (OPD) follow-up
rate), and facility characteristics (admission ward, hospital
accreditation level, and geographic region; Table 1). Stroke
types were categorized as subarachnoid hemorrhage (SAH;
ICD-9-CM code 430); intracerebral hemorrhage (ICH; code
431 for intracerebral hemorrhage and code 432 for other and
unspecified intracranial hemorrhage); ischemic stroke (IS;
code 433 for occlusion and stenosis of precerebral arteries and
code 434 for occlusion of cerebral arteries); and transient
ischemic attack/other unspecified or ill-defined stroke (TIA/
unspecified; code 435 for transient cerebral ischemia, code
436 for acute but ill-defined cerebrovascular disease, and code
437 for other and ill-defined cerebrovascular disease).2.3. Disease severityAs no standardized severity scale was routinely collected in
this claims dataset, three surrogate measures for stroke
severity were constructed from NHI procedure codes and
secondary diagnoses,19 including: (1) respiratory distress or
infections (e.g., oxygen inhalation, endotracheal tube inser-
tion, use of mechanical ventilation, or coding of infection or
aspiration pneumonia); (2) neurosurgery (e.g., microvascular
decompression, craniotomy/cranioplasty, ventriculostomy
with shunting, removal of subdural/epidural hematoma, end-
arterectomy, and bypass surgeries); and (3) Charlson Comor-
bidity Index (CCI), which is used to quantify preexisting or
Table 1
Basic characteristics among four stroke types (N ¼ 2368).
Total (N ¼ 2368) SAH (n ¼ 78) ICH (n ¼ 424) IS (n ¼ 1180) TIA/unspecified (N ¼ 686) p
Demographic characteristics
Age (y) 66.4  13.8 57.7  17.9 61.5 16.2 68.1 11.7 67.3 14.0 <0.001
Sex, male 1342 (56.7) 33 (42.3) 260 (61.3) 690 (58.5) 359 (52.3) 0.001
Onset year
1997e1999 1182 (49.9) 42 (53.8) 196 (46.2) 586 (49.7) 358 (52.2) 0.237
2000e2002 1186 (50.1) 36 (46.2) 228 (53.8) 594 (50.3) 328 (47.8)
Clinical characteristics
Brain imaging 1953 (82.5) 73 (93.6) 393 (92.7) 1060 (89.8) 427 (62.2) <0.001
Respiratory distress or
infections
1036 (43.8) 67 (85.9) 311 (73.3) 449 (38.1) 209 (30.5) <0.001
Neurosurgery 196 (8.3) 34 (43.6) 138 (32.5) 11 (0.9) 13 (1.9) <0.001
Inpatient/outpatient
rehabilitation use
1008 (42.6) 16 (20.5) 207 (48.8) 591 (50.1) 194 (28.3) <0.001
CCI 1.1 1.4 0.6 1.5 0.8 1.4 1.2 1.4 1.0 1.4 <0.001
Initial LOS (d) 15.0 23.1 17.6 19.9 23.0 30.9 15.1 22.4 9.4 16.6 <0.001
Facility characteristics
Admission ward
NW 1204 (50.8) 10 (12.8) 139 (32.8) 776 (65.8) 279 (40.7) <0.001
NS 320 (13.5) 53 (67.9) 195 (46.0) 44 (3.7) 28 (4.1)
GW 844 (35.6) 15 (19.2) 90 (21.2) 360 (30.5) 379 (55.2)
Hospital accreditation level
Medical center 690 (29.1) 44 (56.4) 167 (39.4) 372 (31.5) 107 (15.6) <.001
Regional hospital 927 (39.1) 25 (32.1) 189 (44.6) 478 (40.5) 235 (34.3)
District hospital 751 (31.7) 9 (11.5) 68 (16.0) 330 (28.0) 344 (50.1)
Geographic region
Taipei 633 (26.7) 17 (21.8) 120 (28.3) 317 (26.9) 179 (26.1) 0.004
Northern 359 (15.2) 7 (9.0) 70 (16.5) 178 (15.1) 104 (15.2)
Central 416 (17.6) 23 (29.5) 67 (15.8) 195 (16.5) 131 (19.1)
Southern 424 (17.9) 13 (16.7) 63 (14.9) 243 (20.6) 105 (15.3)
Kao-Ping 456 (19.3) 17 (21.8) 80 (18.9) 217 (18.4) 142 (20.7)
Eastern 80 (3.4) 1 (1.3) 24 (5.7) 30 (2.5) 25 (3.6)
In-hospital mortality 239 (10.1) 37 (47.4) 106 (25.0) 73 (6.2) 23 (3.4) <0.001
Mortality across 1 year
30 d 213 (9.0) 36 (46.2) 96 (22.6) 60 (5.1) 21 (3.1) <0.001
90 d 285 (12.0) 38 (48.7) 121 (28.5) 90 (7.6) 36 (5.2) <0.001
365 d 444 (18.8) 39 (50.0) 152 (35.8) 170 (14.4) 83 (12.1) <0.001
Readmission ratea 923 (43.3) 9 (22.0) 142 (44.7) 482 (43.5) 290 (43.7) 0.048
OPD follow-up rate (visits/month)a 2.9 2.5 1.8 1.3 2.4 1.9 2.9 2.8 3.0 2.4 <0.001
CCI¼Charlson Comorbidity Index; GW¼ general wards, including general medicine and other wards; ICH¼ intracerebral hemorrhage; IS¼ ischemic stroke;
NS¼ neurosurgery wards; NW¼ neurology/rehabilitation wards; OPD¼ outpatient department; SAH¼ subarachnoid hemorrhage; TIA/unspecified¼ transient
ischemic attack/other ill-defined cerebrovascular diseases. NOTE. Data are presented as mean ± SD or n (%).
a N¼ 2129 survivors from initial stroke hospitalization.
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of weighted scores based on the presence or absence of 17
different medical conditions.29 However, cerebrovascular dis-
eases were excluded as they were reflected in the condition
being evaluated.14,15 Higher scores indicated a greater burden
of comorbidity.2.4. Facility characteristicsThe provided hospital characteristics included admission
ward, hospital accreditation level, and hospital location.
Admission wards were classified into neurology/rehabilitation
ward (NW), neurosurgery ward (NS), and general ward/
miscellaneous (GW). Hospital accreditation levels were clas-
sified into medical center, regional hospital, and district hos-
pital on the basis of the hospital bed size, sophistication ofmedical services, and teaching status. The geographic region
was categorized into six regions (Taipei, Northern, Central,
Southern, Kao-Ping, and Eastern).2.5. Brain imagingThe utilization rate of brain imaging was explored by
retrieving NHI procedure codes for brain computed tomogra-
phy (CT) or magnetic resonance image (MRI) during the index
episode, either at the index hospitalization or during the pre-
ceding ER stay.2.6. OPD follow-up rateThe OPD follow-up rate was calculated using the number
of OPD visits divided by the time interval (month) between
706 H.-C. Lee et al. / Journal of the Chinese Medical Association 76 (2013) 703e714discharge from the index stroke and occurrence of the first
adverse event (AE) within the first year. The OPD follow-up
rates were categorized into low (<1.4 visits/month), moder-
ate (1.4-3.7 visits/month), and high (3.80 visits/month) OPD
groups according to quartiles (<25th, 25-75th, and >75th per-
centiles, respectively).2.7. AEs within the first-year after strokeAs no information regarding the patients’ objective or
subjective health status was available in this claims-based
dataset, AEs indicated by composite outcome events of read-
missions or mortality were chosen to fully capture the totality
of negative health outcomes within the first year after index
stroke.3,8,30,31 To differentiate vascular outcomes from general
health outcomes, readmissions were further categorized into
acute vascular-related events versus events from other causes.
Readmissions due to acute stroke (ICD-9-CM 430.xx-437.xx),
intracranial arteriovenous malformation (AVM)/congenital
cerebral aneurysm (ICD-9-CM 747.81), or acute cardiovas-
cular diseases (ICD-9-CM 410.xx, 411.xx, 413.xx, 440.xx,
441.xx) were regarded as acute vascular-related events. In
accordance with other studies in the literature,3,8,30 two end-
points were reported in the current study. The primary com-
posite outcome (AE1) was acute vascular-related readmissions
and all-cause mortality; whereas the secondary composite
outcome (AE2) was all-cause readmissions and mortality over
the first year after index stroke. The Clinical Classifications
System (ICD-9-CM) developed by the Agency for Healthcare
Research and Quality, Rockville, MD, USA,32 was used to
categorize the primary cause for all readmission events. Only
the primary diagnosis code was used to enhance specificity.
Because the linkage of NHI data to the National Death
Registry was not usually available due to privacy protection,
the patients’ mortality status was determined by the record
withdrawal from the NHI program so that the cause of death
cannot be ascertained.14,15 Taiwan’s NHI is a compulsory
single-payer program and therefore the main reason that any
Taiwanese resident withdraws from the program is death or
moving abroad, which is very unlikely in stroke survivors.2.8. First-year medical cost (FYMC)All medical claims to NHI of any cause were collected up
to 1 year after stroke. The FYMC were divided into three
phases: initial hospitalization, readmission, and ambulatory
care costs. Each phase comprised seven components catego-
rized as follows: maintenance (ward, diagnosis, physician fee,
and nursing fee), laboratory tests, imaging, surgery, medica-
tion, rehabilitation, and others. The component “others”
included respiratory support measures, urine catheter care,
nasogastric tube care, dialysis, or any other supportive mea-
sures not listed in the previous six components (Table S1 in the
supplementary material online). As a result of the NHI
perspective that we adopted, our analysis neither included
nursing home or caregiver cost, nor indirect costs such asproductivity losses resulting from early mortality or absence
from work.2.9. Statistical analysisSAS System for Windows, version 8.2 (SAS Institute, Cary,
NC, USA) and SPSS version 16.0 for Windows, (SPSS Inc.,
Chicago, IL, USA) were used for data retrieval, compilation,
and statistical analyses. Chi-square tests for categorical vari-
ables and one-way analysis of variance (ANOVA) for
continuous variables were conducted to compare the basic
characteristics among the four stroke types. Univariate asso-
ciations between basic characteristics and AE were assessed
by Chi-square tests, whereas multivariate Cox proportional-
hazards (Cox-PH) regression analyses was performed to
identify independent predictors for AE1 and AE2. Time in-
terval to AE was calculated from the onset date of index stroke
to occurrence of the first AE. For those survivors without
readmission within 1 year, the data were censored as 365 days.
The initial LOS was regarded as an endogenous variable
within the causal model because it has been shown that the
LOS was determined by the remaining independent vari-
ables27; therefore, the initial LOS was not included in the
multivariate Cox-regression models. The main causes for all
the readmission events were categorized by the Clinical
Classifications System (ICD-9-CM)32 and analyzed for four
stroke types.
One-way ANOVA was used to compare FYMC and cost
components for the four stroke types. Independent cost-driving
factors were determined using stepwise multiple regression
analysis. Given the expected skewness, natural logarithmical
transformation of FYMC as the dependent variable and the
initial LOS as one of the independent variables was per-
formed. The stacked bar charts and pie charts of medical cost
were plotted to demonstrate total FYMC and cost distributions
among the four stroke types. The cost per life saved for the
four stroke types were calculated using the mortality rate and
medical costs during the first year.33 In order to further esti-
mate the cost per life-year saved,33 figures of life expectancy
at birth for males and females in year 2002 were obtained from
the Population Projections for Taiwan: 2010-2060.34 All sig-
nificant tests were two-tailed and differences were considered
to be statistically significant at a p < 0.05 level.
3. Results
Of 2641 acute stroke patients retrieved, 2368 first-ever
stroke samples were selected for analyses of AEs and
FYMC, and 2129 patients who survived the initial hospitali-
zation were used for exploring the main causes of read-
missions (Fig. 1). There were 78 patients (3.3%) with SAH,
424 patients (17.9%) with ICH, 1180 patients (49.8%) with IS,
and 686 patients (29.0%) with TIA/unspecified (12.3% for
TIA, 16.6% for unspecified). The mean age was 66.4  13.8
years with 56.7% males. Patients with SAH or ICH were
younger with less comorbidity, but had greater disease
severity as demonstrated by higher incidences of respiratory
NHI enrollees 
(n  = 23 million)
1996-2003 NHI Cohort Dataset 
(n  = 200,000)
1997-2002 Primary discharge diagnosis of stroke 
(ICD-9-CM codes 430-437) 
Random sampling 
Extracting data from the “hospital 
admission data files”
The first hospitalization during 1997-2002 was 
chosen as the “index stroke” 
Multiple inpatient claims for individuals 
were merged to create a patient level file 
1997-2002 stroke sample 
(n  = 2641) 
Primary discharge diagnosis of acute stroke during 
1996 (n = 105) 
Coded with late effects of stroke prior to the index 
stroke (n = 162) 
Initial LOS > 365 days (n = 3) 
Nonstroke-related causes (n = 3)
1997-2002 First-ever stroke sample 
(n  = 2368) 
1997-2002 First-ever stroke survivor sample 
(n  = 2129) 
Dead at initial discharge (n = 239) 
Subjects excluded 
(n = 273) 
Event (+)
n = 968 
Event (-)
n = 1161 
AE2
SAH 
(n = 78
AE1
)
ICH 
(n = 424)
IS 
(n = 1180)
TIA/unspecified 
(n = 686)
AE2 FYMC
Fig. 1. Patient flow chart. AE1 ¼ composite of acute vascular-related readmissions and all-cause mortality during the first year after index stroke; AE2¼ all-cause
readmission/death during first year after index stroke; FYMC ¼ all direct medical costs during first-year after index stroke; ICH¼ intracerebral hemorrhage;
IS¼ ischemic stroke; LOS¼ length of stay; NHI ¼ National Health Insurance; SAH¼ subarachnoid hemorrhage; TIA/unspecified¼ transient ischemic attack/
other ill-defined cerebrovascular diseases.
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was undertaken in 82.5% of all patients, with the lowest uti-
lization rate (62.2%) among TIA/unspecified patients. Most
SAH and ICH patients were treated at medical centers or
regional hospitals by neurosurgeons, whereas IS and TIA/un-
specified were largely treated at regional or district hospitalsby neurologists or generalists. In total, 29.1%, 39.1%, and
31.7% of stroke patients were admitted to medical centers,
regional hospitals, and district hospitals, respectively, with
50.8%, 13.5%, and 35.6% served in NW, NS, and GW,
respectively. The distribution of hospital levels and geographic
areas in this study sample resembled a previous nationwide
Table 2
Univariate and multivariate analysis of first-year readmission/mortality in relation to baseline characteristics (N¼ 2368).
Acute vascular-related readmissions/all-cause mortality All-cause readmissions/mortality
Univariate analysis Cox-PH regression Univariate analysis Cox-PH regression
N n (%) p HR (95% CI) n (%) p HR (95% CI)
Total 2368 692 (29.2) 1207 (51.0)
Demographic characteristics
Age, y <0.001
64a 928 232 (25.0) 1.00 (Reference) 401 (43.2) 1.00 (Reference)
65-74 782 204 (26.1) 1.12 (0.92e1.35) 387 (49.5) 1.20b (1.04e1.38)
75 658 256 (38.9) 1.6b (1.41e2.02) 419 (63.7) <0.001 1.76b (1.53e2.03)
Sex 0.267 ns 0.806 ns
Male 1342 380 (28.3) 687 (51.2)
Femalea 1026 312 (30.4) 520 (50.7)
Onset year 0.970 ns 0.652 ns
1997e1999a 1182 347 (29.3) 597 (50.5)
2000e2002 1186 345 (29.2) 610 (51.4)
Clinical characteristics
Stroke type <0.001 <0.001
SAH 78 42 (53.8) 3.43b (2.33e5.04) 46 (59.0) 1.87b (1.32ee2.63)
ICH 424 184 (43.4) 2.39b (1.85-3.07) 267 (63.0) 1.75b (1.43-2.13)
IS 1180 313 (26.5) 1.30b (1.06-1.59) 573 (48.6) 1.15 (0.99-1.33)
TIA/unspecifieda 686 153 (22.3) 1.00 (Reference) 321 (46.8) 1.00 (Reference)
Brain imaging 0.115 ns 0.360 ns
Yes 1953 584 (29.9) 987 (50.5)
Noa 415 108 (26.0) 220 (53.0)
Respiratory distress/infections <0.001 <0.001
Yes 1036 449 (43.3) 2.47b (2.09-2.92) 665 (64.2) 1.89b (1.67-2.14)
Noa 1332 243 (18.2) 1.00 (Reference) 542 (40.7) 1.00 (Reference)
Neurosurgery <0.001 <0.001
Yes 196 82 (41.8) 0.60b (0.45-0.81) 125 (63.8) 0.76b (0.59-0.96)
Noa 2172 610 (28.1) 1.00 (Reference) 1082 (49.8) 1.00 (Reference)
Inpatient/outpatient rehabilitation use <0.001 0.370
Yes 1008 248 (24.6) 0.57b (0.48-0.67) 503 (49.9) 0.79b (0.70-0.89)
Noa 1360 444 (32.6) 1.00 704 (51.8) 1.00 (Reference)
CCI <0.001 <0.001
0a 1182 304 (25.7) 1.00 (Reference) 552 (46.7) 1.00 (Reference)
1-2 892 270 (30.3) 1.29b (1.09-1.53) 475 (53.3) 1.23b (1.08-1.39)
3 294 118 (40.1) 1.74b (1.39-2.16) 180 (61.2) 1.46b (1.22-1.74)
Initial LOS (d) <0.001 na <0.001 na
7 1138 322 (28.3) 552 (48.5)
8-15 629 156 (24.8) 301 (47.9)
16-30 327 107 (32.7) 169 (51.7)
31 274 107 (39.1) 185 (67.5)
OPD follow-up rate, visit(s)/monb,c <0.001 na <0.001 na
Low 1.41a 511 127 (24.9) 219 (42.9)
Moderate 1.42-3.79 1086 196 (18.0) 423 (39.0)
High  3.80 532 130 (24.4) 326 (61.3)
Facility characteristics
Admission ward <0.001 <0.001
NW 1204 292 (24.3) 0.84b (0.70-1.00) 540 (44.9) 0.77b (0.68-0.88)
NS 320 140 (43.8) 1.21 (0.93-1.58) 194 (60.6) 1.03 (0.83-1.27)
GWa 844 260 (30.8) 1.00 (Reference) 473 (56.0) 1.00 (Reference)
Hospital accreditation level 0.754 ns 0.071 ns
Medical center 690 198 (28.7) 333 (48.3)
Regional hospital 927 279 (30.1) 467 (50.4)
District hospitala 751 215 (28.6) 407 (54.2)
Geographic region 0.861 ns 0.326 ns
Taipei 633 190 (30.0) 325 (51.3)
Northern 359 104 (29.0) 199 (55.4)
Centrala 416 113 (27.2) 197 (47.4)
Southern 424 126 (29.7) 214 (50.5)
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Table 2 (continued )
Acute vascular-related readmissions/all-cause mortality All-cause readmissions/mortality
Univariate analysis Cox-PH regression Univariate analysis Cox-PH regression
N n (%) p HR (95% CI) n (%) p HR (95% CI)
Kao-Ping 456 132 (28.9) 228 (50.0)
Eastern 80 27 (33.8) 44 (55.0)
CCI¼Charlson Comorbidity Index; CI¼ confidence interval; GW ¼ general wards, including general medicine and other wards; HR¼ hazard ratio;
ICH¼ intracerebral hemorrhage; IS¼ ischemic stroke; LOS¼ length of stay; na¼ non-appropriate to put into the multivariate Cox-PH regression model;
NS¼ neurosurgery wards; ns ¼ nonsignificant; NW¼ neurology/ rehabilitation wards; OPD¼ outpatient department; SAH¼ subarachnoid hemorrhage; TIA/
unspecified¼ transient ischemic attack/other ill-defined cerebrovascular diseases.
a Reference group.
b Statistically significant.
c N¼ 2129 survivors from initial stroke hospitalization.
Fig. 2. FYMC (NT$) and cost distributions among the four stroke types
(N¼ 2368). (A) Cost distribution categorized by three phases among the
four stroke types (N¼ 2368). (B) Cost distribution categorized by seven
components among the four stroke types (N¼ 2368). FYMC¼ first-year
medical cost; ICH¼ intracerebral hemorrhage; IS¼ ischemic stroke;
SAH¼ subarachnoid hemorrhage; TIA/unspecified¼ transient ischemic
attack/ other ill-defined cerebrovascular diseases.
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composition of medical facilities here (Table 1).
During the initial hospitalization, 239 (10.1%) patients
died, with SAH 47.4%, ICH 25.0%, IS 6.2%, and TIA/un-
specified 3.4%. Among 2129 stroke survivors, 968 patients
(45.5%) incurred readmission or mortality of any cause (AE2)
within the first year, with SAH 22.0%, ICH 50.6%, IS 45.2%,
and TIA/unspecified 44.9%, respectively ( p ¼ 0.005). Con-
ditional on 923 patients with readmission(s), 410 patients
(44.4%) were readmitted more than once with an average of
1.9 readmission events per person (Table S1 in the supple-
mentary material online). Patient readmissions were mainly
because of acute recurrent stroke or the late effects of previous
stroke (18.6%), respiratory disease/infections (18.1%), heart/
circulatory disease (10.7%), and diseases of the digestive
system (10.3%) (Table S2 in the supplementary material on-
line). The OPD follow-up rate was 2.9  2.5 visits/month in
average, and it was positively associated with AE2 risk among
survivors from initial hospitalization (hazard ratio
(HR) ¼ 1.64, 95% confidence interval (CI): 1.38-1.95 for high
vs. low OPD group; data not shown).
Taking the total number of first-ever stroke patients alto-
gether (N ¼ 2368), 692 patients (29.2%) encountered acute
vascular-related readmissions or all-cause mortality (AE1)
with SAH 53.8%, ICH 43.4%, IS 26.5%, and TIA/unspecified
22.3% ( p < 0.001); whereas 1207 patients (51.0%) encoun-
tered readmission or mortality of any cause (AE2) with SAH
59.0%, ICH 63.0%, IS 48.6%, and TIA/unspecified 46.8%
( p < 0.001). Advanced age, hemorrhagic stroke type, incur-
ring respiratory distress/infections, and higher CCI were
predictive of increased AE risk, whereas admission to
neurology/rehabilitation wards, undertaking neurosurgery, or
getting inpatient/outpatient rehabilitation services resulted in a
16-43% lower likelihood of AEs (Table 2).
On average, the FYMC was NT$170,376, with NT
$217,959, $246,358, $168,003, and $122,084 for SAH, ICH,
IS, and TIA/unspecified, respectively ( p < 0.001). Forty-four
percent of FYMC ($75,049) was spent in initial hospitaliza-
tion, 29% ($50,164) in readmission, and 27% ($45,163) in
ambulatory care. SAH and ICH were more costly for initial
hospitalization, whereas IS and TIA/unspecified spent more
in the subsequent readmission or ambulatory care phases(Fig. 2A). Maintenance, laboratory, imaging, surgery, medi-
cations, rehabilitation, and others constituted 30%, 6%, 6%,
6%, 22%, 7%, and 23% of FYMC, respectively (Fig. 2B).
Differences in patient and facility characteristics accounted for
a large fraction of variance in FYMC (adjusted R2 ¼ 0.626),
with the initial LOS being the most robust predictor (adjusted
R2 ¼ 0.418; Table 3). The estimated cost per life saved for
Table 3
Univariate and multivariate analysis of FYMC (NT$) in relation to baseline characteristics (N¼ 2368).a
N Univariate analysis Multivariate analysis (lnFYMC) (adjusted R2¼ 0.626)
Mean cost (95% CI) p Unstandardized coefficient Standardized coefficient b p
B SE
(Constant) 9.231 0.051
Total 2368 170,376 (160,419, 180,333)
Demographic characteristics
Age 0.052
64b 928 162,057 (145,902, 178,211)
65-74 782 163,499 (148,398, 178,601)
75 658 190,282 (169,227, 211,336)
Sex 0.114
Male 1342 177,402 (162,681, 192,122) 0.054 0.026 0.027 0.035
Femaleb 1026 161,186 (148,637, 173,736)
Onset year 0.002
1997e1999b 1182 154,879 (142,040, 167,719)
2000e2002 1186 185,821 (170,639, 201,002) 0.119 0.026 0.059 <0.001
Clinical characteristics
Stroke type <0.001
SAH 78 217,959 (168,180, 267,739)
ICH 424 246,358 (216,256, 276,459)
IS 1180 168,003 (155,144, 180,863)
TIA/unspecifiedb 686 122,084 (105,216, 138,953)
Brain imaging <0.001
Yes 1953 182,583 (171,745, 193,421) 0.171 0.036 0.064 <0.001
Nob 415 112,929 (88,558, 137,299)
Respiratory distress/infections <0.001 0.186 0.020 0.139 <0.001
Nob 1332 116,908 (107,651, 126,166)
Minor 647 182,570 (162,497, 202,644)
Major 389 333,175 (298,433, 367,918)
Neurosurgery <0.001 0.226 0.028 0.118 <0.001
Nob 2172 150,604 (141,087, 160,121)
Minor 26 252,745 (168,008, 337,483)
Major 170 410,398 (356,364, 464,431)
Inpatient/outpatient
rehabilitation use
<0.001 0.095 0.029 0.047 0.001
Yes 1008 220,544 (205,044, 236,043)
Nob 1360 133,193 (120,551, 145,835)
CCI <0.001 0.060 0.009 0.083 <0.001
0b 1182 141,314 (129,292, 15,333)
1-2 892 172,217 (156,955, 187,479)
3 294 281,632 (239,550, 323,713)
Initial LOS (d)c <0.001 0.448 0.015 0.459 <0.001
7 1138 96,054 (87,323, 104,784)
8e15 629 146,140 (126,999, 165,282)
16e30 327 209,590 (188,758, 230,422)
31 274 487,894 (445,545, 530,244)
OPD follow-up rate
(visits/month)
0.001 NA
Dead at initial discharge 239 188,541 (154,082, 222,999)
Low 1.40 511 169,700 (145,602, 193,798)
Moderate 1.41e3.79 1086 150,926 (137,954, 163,898)
High 3.80 532 202,570 (180,597, 224,542)
Readmission/death status <0.001
Alive, nonreadmittedb 1161 97,233 (90,623, 103,842)
Alive, ever readmitted 763 243,696 (221,424, 265,969) 0.754 0.028 0.350 <0.001
Dead at initial discharge 239 188,541 (154,082, 222,999)
Dead, ever readmitted 160 336,183 (279,327, 393,039) 0.953 0.053 0.237 <0.001
Dead, nonreadmitted 45 128,279 (82,551, 174,008) 0.263 0.094 0.036 0.005
Facility characteristics
Care model <0.001
NW 1204 164,176 (150,738, 177,613)
NS 320 268,717 (233,087, 304,348)
GWb 844 141,935 (127,356, 156,514)
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Table 3 (continued )
N Univariate analysis Multivariate analysis (lnFYMC) (adjusted R2¼ 0.626)
Mean cost (95% CI) p Unstandardized coefficient Standardized coefficient b p
B SE
Hospital accreditation level <0.001
Medical center 690 222,082 (200,139, 244,025) 0.294 0.035 0.132 <0.001
Regional hospital 927 173,550 (157,304, 189,796) 0.186 0.033 0.090 <0.001
District hospitalb 751 118,951 (106,556, 131,347)
Geographic region 0.005
Taipei 633 203,674 (181,720, 225,627)
Northern 359 145,964 (129,171, 162,757) 0.130 0.037 0.046 <0.001
Centralb 416 162,543 (140,491, 184,597)
Southern 424 162,218 (136,588, 187,848)
Kao-Ping 456 159,869 (136,449, 183,289) 0.120 0.034 0.047 <0.001
Eastern 80 160,314 (121,436, 199,192)
CCI¼Charlson Comorbidity Index; CI¼ confidence interval; GW ¼ general wards, including general medicine and other wards; ICH¼ intracerebral hemorrhage;
IS¼ ischemic stroke; LOS¼ length of stay; na¼ non-appropriate to put into the stepwise multiple linear regression model; NS ¼ neurosurgery wards; NW ¼
neurology/rehabilitation wards; OPD¼ outpatient department; SAH¼ subarachnoid hemorrhage; SE¼ standard error; TIA/unspecified¼ transient ischemic
attack/other ill-defined cerebrovascular diseases.
a The top five explanatory variables: Initial LOS (ln), alive/dead with at least one readmission, undertaking neurosurgery, and taking brain imaging during index
hospitalization.
b Reference group.
c Initial LOS (d) was natural log transformed prior to regression.
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($196,281) or TIA/unspecified ($138,888). Given that
deceased patients among IS (73.8 years) or TIA/unspecified
(75.0 years) were older and came closer to approaching their
reasonable life expectancy relative to SAH (60.5 years) or ICH
(64.6 years), the estimated cost per life-year saved for IS
($97,830) or TIA/unspecified ($188,779) became higher than
that of SAH ($43,926) or ICH ($48,019; Table S3 in the
supplementary material online).
4. Discussion
By longitudinal claims data, this study reported that half of
the patients encountered readmission or death during the first
year following stroke. With brain imaging used on 82.5% of
patients, 15 days for the initial LOS, and an average 2.9 times/
month OPD follow-up rate for survivors after discharge, initial
hospitalization consumed 44% of the FYMC. Patients who
suffered from SAH had the highest mortality rate, whereas
patients with ICH consumed the highest FYMC. Though
minimal in neurological deficits, patients with TIA/unspecified
consumed the lowest FYMC, but carried almost the same AE
risk. The study period was immediately prior to the intro-
duction of hospital global budgeting into Taiwan’s NHI pro-
gram since July 2002; therefore, the results were less likely to
be contaminated by the cuts in reimbursement associated with
global budgeting.14 Our obtained data has served as important
fundamental information to compare with data currently
available to examine the secular trend in stroke care.
This study found that 45.5% of those who survived initial
hospitalization incurred readmission or mortality within the
first year after stroke, which was comparable with previous
reports varying from 31% to 53%.3,4,6,7,11 Readmissions were
mainly from acute recurrent stroke or late effects of previousstroke, respiratory disease/infections, or heart/circulatory dis-
ease,3,6,7,11 which could be amenable with measures that relied
heavily on the transitional and outpatient care after acute
hospitalization.3,6,8,9,11,12,21,35,36 This study utilized the OPD
visit rate during the first year to signify the efforts of post-
discharge outpatient care. As the positive association of OPD
visits with the risk of AEs was shown, the intensive OPD
follow-up did not seem to avoid readmission or mortality.
Rather, it was speculated that a segment of our stroke survi-
vors might be fragile and those AEs might not be easily pre-
vented, even with improved transitional and outpatient
care.9,10,12,21 Nonetheless, the observed 16-43% lower likeli-
hood of AEs in those patients who were admitted to
neurology/rehabilitation wards or received inpatient/outpatient
rehabilitation services reinforced the importance of organized
stroke care as recommended by current practice guidelines.37
From 1 month to 1 year, the mortality rates were
46.2e50.0% in SAH patients; this appeared to be relatively
higher than reported elsewhere, which ranged from 20% to
44% at 1 month26,3841 and from 27.5% to 58.5% over 1
year.39,42 Owing to the sparse number of SAH patients, and
given that the study period was near the edge of application of
endovascular coiling, future studies will be needed to provide
updates in this regard. The mortality rates were 22.6e35.8%
among ICH patients, which were higher than those in Japan,
but seemed comparable to other countries with a pooled mean
of 40.4% (13.1-61.0%) at 1 month26,39,43,44 and 54.7% (38.0-
63.6%) over 1 year.4,39,4245 The mortality rates were 5.1-
14.4% among IS patients; again, the figures were higher than
in Japan (7.0% at 1 year),46 and similar to previous reports
from Taiwan,14,16 but lower than reported elsewhere ranging
from 22.0% to 39.9% over 1 year.4,9,26,39,42,45,47 In particular,
the findings of low utilization of brain imaging initially
(62.2%) and high AE rate subsequently (AE2 46.8%) among
712 H.-C. Lee et al. / Journal of the Chinese Medical Association 76 (2013) 703e714TIA/unspecified patients have signified that the diagnosis and
management for that group might be far from optimal. Early
differential diagnosis and risk stratification along with well-
organized follow-up care are required to prevent subsequent
occurrence of stroke or cardiovascular events after TIA or
unspecified stroke.30,46,48,49
In this study, the initial hospitalization costs represented
44% of FYMC, with readmission and ambulatory care repre-
senting 29% and 27% of FYMC, respectively. The initial LOS,
which is a possible surrogate for initial stroke severity in the
administrative claims dataset,7,17,27 was the main cost-driving
factor identified in this study.50 ICH incurred the highest
FYMC (NT $246,358 or US $7,550), followed by SAH (NT
$217,959 or US $6,680), IS (NT $168,003 or US $5,149), and
TIA/unspecified (NT $122,084 or US $3,741; 1 USD ¼ 32.63
NTD during the study period). The FYMC of SAH or ICH in
this study was roughly approximate to the most expensive
major cancer, leukemia, in Taiwan (NT $207,000),51 which
characterized the heavy disease burden after stroke. However,
the annual health expenditure per case observed in this study
was far lower than reports from Western countries, which
ranged from US $21,772 (The Netherlands),52 US $29,910
(Germany)53 to US $44,170 (USA)54 for SAH; US $21,555
(United Kingdom)4 to US $32,310 (USA)54 for ICH; and US
$21,696 (United Kingdom)4 to US$31,519 (USA)54 for IS.
This underscored the importance of acquiring local cost data
for the economic evaluation of healthcare programs in Taiwan.
The NHIRD originated from an administrative database
whose main function is reimbursement, and it could have
unknown or questionable validity of clinical information. One
recent study demonstrated a high accuracy (94.5%) of the
NHIRD in recording IS diagnoses (ICD-9-CM codes of 433.xx
and 434.xx) but less satisfactory results for recording comor-
bidities (overall agreement was 48.4%) by comparing records
in the NHIRD with those confirmed by radiology examination
and clinical presentation.55 However, those were highly se-
lective cases from one medical center using the code 434.xx
and 433.xx only, and the generalizability of these results is
doubtful. Errors in assigning ICD-9 codes can be caused by
ambiguous descriptions made by physicians, coder’s misun-
derstanding, or by miscoding a written diagnosis. In ischemic
stroke, the neurologic symptoms often cannot be relied upon
to identify the cause of ischemia because the symptoms are
usually transient and do not correlate closely with the presence
or absence of the infarction. The CT and MRI reports are
required to provide definitive infarction diagnosis and infarc-
tion location to validate an IS diagnosis.55 Incorrect or
equivocal coding of discharge diagnoses can also result when
initial diagnoses based on clinical impressions are not updated
during hospitalization after additional laboratory tests and
clinical examinations have been performed.55 In the current
study, the low utilization of brain imaging in TIA/unspecified
patients to confirm the diagnostic code might partially account
for the unexpectedly higher proportion of that subgroup.
Among the 686 TIA/unspecified cases, the majority were
diagnosed from the general wards (55.2%) or the district
hospitals (50.1%); it was probable that the NHIRD codingmight be more accurate in the neurological wards or in the
medical centers.
Using claims data from a nationally representative cohort
under a universal health insurance program, this study was
very likely to include relevant stroke patients with less se-
lection bias encountered by hospital-based studies, studies
from restricted geographic areas, or clinical trials with strict
inclusion or exclusion criteria. Although the study does
incorporate unavoidable errors in the ICD coding within the
NHIRD, the records for events of readmissions or mortality as
well as the medical resource utilizations and related costs were
believed to be more reliable, given its main function was for
reimbursement. This study provided meaningful descriptions
and analyses of AE risk and FYMC after stroke with disag-
gregation of stroke subtype, severity proxies, age, comorbidity,
and physician/facility- related characteristics, all of which
were likely to be relevant parameters in estimating the cost-
effectiveness of specific prevention or intervention strategies
for stroke.
In conclusion, half of the patients experienced readmission
or death during the first year after stroke. Those patients with
advanced age and more complications or comorbidities during
the initial stay tended to be highly vulnerable to AE occur-
rence, whereas TIA/unspecified stroke carried no less risk for
AEs. Initial hospitalization, readmission, and ambulatory care
constituted 44%, 29%, and 27% of FYMC, respectively, with
the initial LOS being the most robust predictor. FYMC or
estimated cost per life saved for IS or TIA/unspecified was
lower relative to SAH or ICH; however, their estimated cost
per life-year saved became higher owing to reduced life
expectancy.
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